General
Preferred name
NEBIVOLOL
Synonyms
NEBIVOLOL HYDROCHLORIDE ()
R 065824 hydrochloride ()
Nebivolol HCl ()
R-65824 ()
R067555 ()
Bystolic ()
RO67555 ()
R-067555 ()
Nebivolol hydrochloride component of byvalson ()
R65,824 ()
Narbivolol ()
Hypoloc ()
Nebivolol component of byvalson ()
Nebilet ()
(±)-Nebivolol-d4 (hydrochloride) ()
P&D ID
PD009358
CAS
118457-14-0
104365-59-5
99200-09-6
152520-56-4
2701283-32-9
Tags
available
drug
biased GPCR ligand
Approved by
FDA
First approval
2007
Drug indication
Hypertension
Cardiovascular disease
Drug Status
approved
investigational
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE 35
DESCRIPTION Nebivolol is a β-blocker, selective for β1-adrenoceptors.
Marketed formulations may contain nebivolol hydrochloride (PubChem CID ). (GtoPdb)
DESCRIPTION Nebivolol hydrochloride (R 065824 hydrochloride) is a cardioselective ADRENERGIC BETA-1 RECEPTOR ANTAGONIST (beta-blocker) that functions as a VASODILATOR through the endothelial L-arginine/ NITRIC OXIDE system. It is used to manage HYPERTENSION and chronic HEART FAILURE in elderly patients. (TargetMol Bioactive Compound Library)
Compound Sets
22
Cayman Chemical Bioactives
ChEMBL Approved Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Guide to Pharmacology
Ki Database
Prestwick Chemical Library
ReFrame library
TargetMol Bioactive Compound Library
The Spectrum Collection
External IDs
52
Properties
(calculated by RDKit )
Molecular Weight
405.18
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
3
Rotatable Bonds
6
Ring Count
4
Aromatic Ring Count
2
cLogP
2.36
TPSA
70.95
Fraction CSP3
0.45
Chiral centers
4.0
Largest ring
6.0
QED
0.69
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Adrenergic Receptor
Apoptosis
β1-adrenoceptor
Pathway
GPCR/G protein
Neuroscience
Therapeutic Class
Antihypertensive Agents
VGSC Target
Nav1.5
Source data